Marcella Mottolese

Overview

Best Publications

• Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation

  Silvia Di Agostino;Sabrina Strano;Velia Emiliozzi;Valentina Zerbini

  486
  Citations

• The α3β1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (mmp‐9) activity

  Monica Morini;Marcella Mottolese;Nicoletta Ferrari;Federica Ghiorzo

  365
  Citations

• TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

  M Bartucci;R Dattilo;C Moriconi;A Pagliuca

  354
  Citations

• The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets

  Enzo Medico;Mariangela Russo;Gabriele Picco;Carlotta Cancelliere

  305
  Citations

• Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect

  Erica Salvati;Carlo Leonetti;Angela Rizzo;Marco Scarsella

  280
  Citations

• The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis

  Giulia Fontemaggi;Stefania Dell'Orso;Daniela Trisciuoglio;Tal Shay

  231
  Citations

• miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer

  A Sacconi;F Biagioni;V Canu;F Mori

  214
  Citations

• KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy.

  Emanuele Valtorta;Sandra Misale;Andrea Sartore-Bianchi;Iris D. Nagtegaal

  212
  Citations

• Immunohistochemical expression of p16 INK4a is predictive of HR-HPV infection in cervical low-grade lesions

  Maria Benevolo;Marcella Mottolese;Ferdinando Marandino;Giuseppe Vocaturo

  193
  Citations

• Breast cancer is associated with loss of the c-kit oncogene product.

  P. G. Natali;M. R. Nicotra;I. Sures;M. Mottolese

  191
  Citations

• Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

  G. Metro;J. Foglietta;M. Russillo;L. Stocchi

  189
  Citations

• c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings.

  Annamaria Biroccio;Barbara Benassi;Igea D’Agnano;Carmen D’Angelo

  174
  Citations

• Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line

  Annamaria Biroccio;Antonio Candiloro;Marcella Mottolese;Orazio Sapora

  172
  Citations

• A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences

  Abeer M. Shaaban;Graham R. Ball;Rebecca A. Brannan;Rebecca A. Brannan;Gabor Cserni

  148
  Citations

• Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer.

  Maria Benevolo;Marcella Mottolese;Maurizio Cosimelli;Manfredo Tedesco

  146
  Citations

• Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.

  Carlo Leonetti;Annamaria Biroccio;Antonio Candiloro;Gennaro Citro

  141
  Citations

• Triple positive breast cancer: a distinct subtype?

  Patrizia Vici;Laura Pizzuti;Clara Natoli;Teresa Gamucci

  139
  Citations

• Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

  Simona Nanni;Valentina Benvenuti;Annalisa Grasselli;Carmen Priolo

  137
  Citations

• Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl-2

  Simonetta Buglioni;Igea D'Agnano;Maurizio Cosimelli;Stefania Vasselli

  129
  Citations

• Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.

  G. Ferrandina;F.O. Ranelletti;L. Lauriola;F. Fanfani

  129
  Citations